40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
49.12%
Net income growth at 50-75% of CRK's 77.13%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-100.00%
Negative yoy D&A while CRK is 7.26%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-79.38%
Negative yoy deferred tax while CRK stands at 72.40%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-100.00%
Both cut yoy SBC, with CRK at -4.88%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
1185.19%
Slight usage while CRK is negative at -56.49%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
7.94%
AR growth is negative or stable vs. CRK's 97.16%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
No Data
No Data available this quarter, please select a different quarter.
100.00%
A yoy AP increase while CRK is negative at -349.45%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
26.41%
Some yoy usage while CRK is negative at -666.44%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
1749.16%
Some yoy increase while CRK is negative at -103.54%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
1.38%
Operating cash flow growth below 50% of CRK's 17.46%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
12.29%
CapEx growth well above CRK's 3.13%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Some acquisitions while CRK is negative at -254.55%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
238.11%
Growth well above CRK's 275.26%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
18.24%
Investing outflow well above CRK's 2.26%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-86.82%
We cut debt repayment yoy while CRK is 159.88%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
11.41%
Buyback growth below 50% of CRK's 200.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.